Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-08 3:14 pm Sale |
2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Sio Capital Management, LLC | 2,582,655 3.630% |
-1,464,142 (-36.18%) |
Filing History |
| 2025-04-01 9:40 pm Purchase |
2025-03-28 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Partners III, L.P. | 4,089,975 5.700% |
4,089,975 (New Position) |
Filing History |
| 2025-03-12 4:05 pm Sale |
2025-03-10 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 5,425,425 7.600% |
-1,677,544 (-23.62%) |
Filing History |
| 2025-02-14 6:09 pm Purchase |
2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
BANK OF AMERICA CORP BAC |
4,616,536 6.500% |
4,616,536 (New Position) |
Filing History |
| 2025-02-13 08:59 am Sale |
2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Flynn James E | 534,737 0.760% |
-6,180,764 (-92.04%) |
Filing History |
| 2025-02-10 12:59 pm Purchase |
2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Sio Capital Management, LLC | 4,046,797 5.720% |
4,046,797 (New Position) |
Filing History |
| 2025-01-29 6:58 pm Purchase |
2025-01-22 | 13G | Ventyx Biosciences, Inc. VTYX |
Point72 Asset Management, L.P. | 4,400,325 6.200% |
4,353,640 (+9325.56%) |
Filing History |
| 2024-11-14 7:54 pm Sale |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
Point72 Asset Management, L.P. | 46,685 0.100% |
-2,970,408 (-98.45%) |
Filing History |
| 2024-11-14 3:06 pm Sale |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
Cormorant Asset Management LP | 0 0.000% |
-3,670,000 (Position Closed) |
Filing History |
| 2024-11-14 08:57 am Purchase |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
Flynn James E | 6,715,501 9.500% |
3,173,501 (+89.60%) |
Filing History |
| 2024-11-12 5:45 pm Unchanged |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
The Vanguard Group | 3,467,721 4.900% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:46 pm Sale |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
The Vanguard Group | 3,467,721 4.900% |
-274,204 (-7.33%) |
Filing History |
| 2024-06-26 5:16 pm Sale |
2024-06-24 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 7,102,969 10.100% |
-1,336,666 (-15.84%) |
Filing History |
| 2024-04-04 12:52 pm Purchase |
2024-03-15 | 13G | Ventyx Biosciences, Inc. VTYX |
Flynn James E | 3,542,000 5.030% |
3,542,000 (New Position) |
Filing History |
| 2024-03-21 4:02 pm Purchase |
2024-03-11 | 13G | Ventyx Biosciences, Inc. VTYX |
Cormorant Asset Management LP | 3,670,000 5.210% |
3,670,000 (New Position) |
Filing History |
| 2024-03-13 6:04 pm Unchanged |
2024-03-11 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 8,439,635 12.000% |
0 (Unchanged) |
Filing History |
| 2024-03-08 4:05 pm Sale |
2024-03-06 | 13D | Ventyx Biosciences, Inc. VTYX |
NSV Investments I, L.P. | 8,439,635 14.200% |
-117,231 (-1.37%) |
Filing History |
| 2024-02-23 4:28 pm Purchase |
2024-02-22 | 13G | Ventyx Biosciences, Inc. VTYX |
Point72 Asset Management, L.P. | 3,017,093 5.100% |
3,017,093 (New Position) |
Filing History |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 4,279,553 7.300% |
490,758 (+12.95%) |
Filing History |
| 2024-02-13 5:16 pm Purchase |
2023-12-29 | 13G | Ventyx Biosciences, Inc. VTYX |
The Vanguard Group | 3,741,925 6.340% |
3,741,925 (New Position) |
Filing History |